Showing results (291-300 of 319) with videos related to

Sort By:
Pageof 32
Oncogene|August 17, 2022
SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activationXiaosong Hu, Ruochen Liu, Jianbing Hou, et al.
Nutrients|October 18, 2018
The Glucose-Lowering Effect of Foxtail Millet in Subjects with Impaired Glucose Tolerance: A Self-Controlled Clinical TrialXin Ren, Ruiyang Yin, Dianzhi Hou, et al.
Frontiers in Immunology|November 25, 2022
Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3-9-month intervals following two-dose inactivated vaccine (CoronaVac)Yuting Liao, Yingping Chen, Bo Chen, et al.
Food Chemistry: X|March 4, 2024
High hydrostatic pressure induced gastrointestinal digestion behaviors of quercetin-loaded casein delivery systems under different calcium concentrationMinjie Liao, Wei Li, Lu Peng, et al.
Comprehensive Reviews in Food Science and Food Safety|March 30, 2026
Engineered Food Matrix: Precision Processing Strategies to Enhance Bioavailability of Bioactive PhytochemicalsJiahao Li, Huijuan Zhu, Xin Yuan, et al.
Oncogene|April 23, 2022
CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expressionWen Peng, Shuang Shi, Jiacheng Zhong, et al.
BMC Neuroscience|December 31, 2015
Limb remote ischemic postconditioning protects cerebral ischemia from injury associated with expression of HIF-1α in ratsYonghua Zong, Ling Jiang, Mingxiao Zhang, et al.
The Analyst|September 27, 2021
A sandwich-type photoelectrochemical aptasensor using Au/BiVO4 and CdS quantum dots for carcinoembryonic antigen assayNan Zhou, Xiaofan Xu, Xi Li, et al.
Cell Death & Disease|March 1, 2024
OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathwayMingxin Ci, Gaichao Zhao, Chongyang Li, et al.
Vaccine|August 5, 2020
Efficacy and safety of a live attenuated influenza vaccine in Chinese healthy children aged 3-17 years in one study center of a randomized, double-blind, placebo-controlled phase 3 clinical trial, 2016/17 seasonShenyu Wang, Yihong Zheng, Xiongyuan Jin, et al.
Pageof 32